Galectin Therapeutics (FRA:PHPN) FFO


FRA:PHPN Galectin Therapeutics Inc FRA:PHPN
22 GF Score
Price €3.76
! 5 Warning Signs
View Full Analysis

What is Galectin Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

FRA:PHPN
22GF Score
Galectin Therapeutics Inc FRA:PHPN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galectin Therapeutics Business Description

Other Exchanges GALT:USAPHPN:Germany
Address 4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA, USA, 30071
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
22GF Score

Get the complete analysis for FRA:PHPN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.76
Price